Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.01 HKD
−128.30 M HKD
2.38 B HKD
1.31 B
About VIVA BIOTECH HOLDINGS
Sector
Industry
CEO
Chen Mao
Website
Headquarters
Shanghai
Founded
2008
FIGI
BBG00NZ74JJ9
Viva Biotech Holdings engages in the discovery, development, and manufacturing of clinical drugs. It operates through Drug Discovery, and Contract Development Manufacture Organisation (“CDMO”) and Commercialization segments. The Drug Discovery segment involves in structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage innovative drug development. The Contract Development Manufacture Organisation (“CDMO”) and Commercialization segment consists of contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations. The company was founded by Feng Mao Hua, Chen Cheney Mao and Ying Wu on August 27, 2008 and is headquartered in Shanghai, China.
Viva Biotech (1873.HK) Good Sign to buy!?Share price of Viva Biotech (1873.HK) was up by 19.6% to $10.44 today (5th Aug 2020).
The share price has been passed over the last highest price ($10.16) one month ago on 7th Jul 2020.
Pivot point was existed and come together with a high volume and was ended up to the highest price.
Therefore, it
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 1873 is 0.99 HKD — it has increased by 2.15% in the past 24 hours. Watch VIVA BIOTECH HOLDINGS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange VIVA BIOTECH HOLDINGS stocks are traded under the ticker 1873.
1873 stock has risen by 2.15% compared to the previous week, the month change is a 2.15% rise, over the last year VIVA BIOTECH HOLDINGS has showed a −24.43% decrease.
1873 reached its all-time high on Jun 23, 2021 with the price of 11.64 HKD, and its all-time low was 0.41 HKD and was reached on Apr 19, 2024. View more price dynamics on 1873 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1873 stock is 6.45% volatile and has beta coefficient of 2.35. Track VIVA BIOTECH HOLDINGS stock price on the chart and check out the list of the most volatile stocks — is VIVA BIOTECH HOLDINGS there?
Today VIVA BIOTECH HOLDINGS has the market capitalization of 2.03 B, it has increased by 5.49% over the last week.
Yes, you can track VIVA BIOTECH HOLDINGS financials in yearly and quarterly reports right on TradingView.
VIVA BIOTECH HOLDINGS is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
1873 net income for the last half-year is 126.58 M HKD, while the previous report showed −126.54 M HKD of net income which accounts for 200.03% change. Track more VIVA BIOTECH HOLDINGS financial stats to get the full picture.
As of Nov 5, 2024, the company has 2.08 K employees. See our rating of the largest employees — is VIVA BIOTECH HOLDINGS on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VIVA BIOTECH HOLDINGS EBITDA is 423.90 M HKD, and current EBITDA margin is 18.74%. See more stats in VIVA BIOTECH HOLDINGS financial statements.
Like other stocks, 1873 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VIVA BIOTECH HOLDINGS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VIVA BIOTECH HOLDINGS technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VIVA BIOTECH HOLDINGS stock shows the sell signal. See more of VIVA BIOTECH HOLDINGS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.